150 related articles for article (PubMed ID: 15994949)
1. Mosaic tumor vessels: cellular basis and ultrastructure of focal regions lacking endothelial cell markers.
di Tomaso E; Capen D; Haskell A; Hart J; Logie JJ; Jain RK; McDonald DM; Jones R; Munn LL
Cancer Res; 2005 Jul; 65(13):5740-9. PubMed ID: 15994949
[TBL] [Abstract][Full Text] [Related]
2. Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers.
Minhajat R; Mori D; Yamasaki F; Sugita Y; Satoh T; Tokunaga O
Virchows Arch; 2006 Feb; 448(2):127-34. PubMed ID: 16177881
[TBL] [Abstract][Full Text] [Related]
3. Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors.
Baluk P; Morikawa S; Haskell A; Mancuso M; McDonald DM
Am J Pathol; 2003 Nov; 163(5):1801-15. PubMed ID: 14578181
[TBL] [Abstract][Full Text] [Related]
4. Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood.
Chang YS; di Tomaso E; McDonald DM; Jones R; Jain RK; Munn LL
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14608-13. PubMed ID: 11121063
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
Takahashi N; Haba A; Matsuno F; Seon BK
Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas.
Ding I; Sun JZ; Fenton B; Liu WM; Kimsely P; Okunieff P; Min W
Cancer Res; 2001 Jan; 61(2):526-31. PubMed ID: 11212245
[TBL] [Abstract][Full Text] [Related]
7. Endoglin is a suitable target for efficient imaging of solid tumors: in vivo evidence in a canine mammary carcinoma model.
Fonsatti E; Jekunen AP; Kairemo KJ; Coral S; Snellman M; Nicotra MR; Natali PG; Altomonte M; Maio M
Clin Cancer Res; 2000 May; 6(5):2037-43. PubMed ID: 10815930
[TBL] [Abstract][Full Text] [Related]
8. The differences between the endothelial area marked with CD31 and CD105 in colorectal carcinomas by computer-assisted morphometrical analysis.
Jung I; Gurzu S; Raica M; Cîmpean AM; Szentirmay Z
Rom J Morphol Embryol; 2009; 50(2):239-43. PubMed ID: 19434317
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome.
Dales JP; Garcia S; Andrac L; Carpentier S; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Charpin C
Int J Oncol; 2004 May; 24(5):1197-204. PubMed ID: 15067342
[TBL] [Abstract][Full Text] [Related]
10. Endoglin (CD105) expression in endometrial carcinoma.
Saad RS; Jasnosz KM; Tung MY; Silverman JF
Int J Gynecol Pathol; 2003 Jul; 22(3):248-53. PubMed ID: 12819391
[TBL] [Abstract][Full Text] [Related]
11. Tumor origin of endothelial cells in human neuroblastoma.
Pezzolo A; Parodi F; Corrias MV; Cinti R; Gambini C; Pistoia V
J Clin Oncol; 2007 Feb; 25(4):376-83. PubMed ID: 17264333
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma.
Raica M; Cimpean AM; Anghel A
Neoplasma; 2007; 54(4):278-84. PubMed ID: 17822316
[TBL] [Abstract][Full Text] [Related]
13. Intra-epithelially entrapped blood vessels in ameloblastoma.
Siar CH; Ishak I; Ng KH
J Oral Pathol Med; 2015 May; 44(5):378-85. PubMed ID: 25155411
[TBL] [Abstract][Full Text] [Related]
14. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in esophageal adenocarcinoma.
Saad RS; El-Gohary Y; Memari E; Liu YL; Silverman JF
Hum Pathol; 2005 Sep; 36(9):955-61. PubMed ID: 16153457
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.
Tanaka F; Otake Y; Yanagihara K; Kawano Y; Miyahara R; Li M; Yamada T; Hanaoka N; Inui K; Wada H
Clin Cancer Res; 2001 Nov; 7(11):3410-5. PubMed ID: 11705856
[TBL] [Abstract][Full Text] [Related]
16. Various immunostaining patterns of CD31, CD34 and endoglin and their relationship with lymph node metastasis in oral squamous cell carcinomas.
Nagatsuka H; Hibi K; Gunduz M; Tsujigiwa H; Tamamura R; Sugahara T; Sasaki A; Nagai N
J Oral Pathol Med; 2005 Feb; 34(2):70-6. PubMed ID: 15641985
[TBL] [Abstract][Full Text] [Related]
17. Morphologic research of microcirculation patterns in human and animal melanoma.
Zhang S; Zhang D; Wang Y; Zhao W; Guo H; Zhao X; Sun B
Med Oncol; 2006; 23(3):403-9. PubMed ID: 17018898
[TBL] [Abstract][Full Text] [Related]
18. Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin.
Seon BK; Matsuno F; Haruta Y; Kondo M; Barcos M
Clin Cancer Res; 1997 Jul; 3(7):1031-44. PubMed ID: 9815781
[TBL] [Abstract][Full Text] [Related]
19. Openings between defective endothelial cells explain tumor vessel leakiness.
Hashizume H; Baluk P; Morikawa S; McLean JW; Thurston G; Roberge S; Jain RK; McDonald DM
Am J Pathol; 2000 Apr; 156(4):1363-80. PubMed ID: 10751361
[TBL] [Abstract][Full Text] [Related]
20. Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma.
Behrem S; Zarkovic K; Eskinja N; Jonjic N
Croat Med J; 2005 Jun; 46(3):417-22. PubMed ID: 15861521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]